Robert Carr
Impact in
- Pharmaceutical Science top 1%
- Drug Solubulity and Delivery Systems
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 12
-
- Neonatal and Maternal Infections 5
- Acute Lymphoblastic Leukemia research 4
- Co-authors
- Neena Modi (5 shared papers)Caroline J Doré (5 shared papers)Sally Fiona Barrington (4 shared papers)Arik Dahan (2 shared papers)Jonathan M. Miller (2 shared papers)Avital Beig (2 shared papers)Jon D. van der Walt (3 shared papers)Michael J. O'Doherty (2 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Archives of Disease in Childhood Fetal & Neonatal (3 papers)Journal of Nuclear Medicine (3 papers)Blood (3 papers)British Journal of Haematology (3 papers)
- Partner nations
- United KingdomUnited StatesHungary
In The Last Decade
Robert Carr
71 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 152
- Pharmaceutical Science 252
- Pathology and Forensic Medicine 549
- Hematology 324
- Immunology 386
- Biochemistry 104
Countries citing papers authored by Robert Carr
This map shows the geographic impact of Robert Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Carr more than expected).
Fields of papers citing papers by Robert Carr
This network shows the impact of papers produced by Robert Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Carr. The network helps show where Robert Carr may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Carr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 248 | |
| 2 | 2013 | 190 | |
| 3 | 2011 | 182 | |
| 4 | 2003 | 178 | |
| 5 | 2014 | 163 | |
| 6 | 2000 | 162 | |
| 7 | 2010 | 139 | |
| 8 | 2002 | 137 | |
| 9 | 2009 | 124 | |
| 10 | 1990 | 119 | |
| 11 | 2012 | 118 | |
| 12 | 2009 | 103 | |
| 13 | 2005 | 74 | |
| 14 | 2008 | 70 | |
| 15 | 1999 | 58 | |
| 16 | 2021 | 58 | |
| 17 | 2014 | 58 | |
| 18 | 2014 | 55 | |
| 19 | 2006 | 45 | |
| 20 | Phase I dose-escalation study of the safety and pharmacokinetics of atrasentan: an endothelin receptor antagonist for refractory prostate cancer. | 2003 | 41 |
About Robert Carr
Robert Carr is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health, Cultural Studies, Oncology and Hematology, having authored 75 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (12 papers), Neonatal and Maternal Infections (5 papers), Analytical Chemistry and Chromatography (5 papers), Medical Imaging Techniques and Applications (5 papers), Angiogenesis and VEGF in Cancer (5 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Hematological disorders and diagnostics (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). The work is most often cited by research in Pharmaceutical Science (252 citations), Pathology and Forensic Medicine (549 citations), Hematology (324 citations), Immunology (386 citations) and Biochemistry (104 citations). Robert Carr has collaborated with scholars based in United Kingdom, United States and Hungary. Frequent co-authors include Neena Modi, Caroline J Doré, Sally Fiona Barrington, Arik Dahan, Jonathan M. Miller, Avital Beig, Jon D. van der Walt, Michael J. O'Doherty, Bella Madan and Tim Peter Morris. Their work appears in journals such as Journal of Clinical Oncology, Archives of Disease in Childhood Fetal & Neonatal, Journal of Nuclear Medicine, Blood and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.